Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

BACKGROUND: Little is known about the factors that predict for gastrointestinal stromal tumor (GIST) recurrence in patients treated with adjuvant imatinib. METHODS: Risk factors for GIST recurrence were identified, and 2 risk stratification scores were developed using the database of the Scandinavia...

詳細記述

保存先:
書誌詳細
主要な著者: Joensuu, Heikki, Eriksson, Mikael, Hall, Kirsten Sundby, Hartmann, Jörg T, Pink, Daniel, Schütte, Jochen, Ramadori, Giuliano, Hohenberger, Peter, Duyster, Justus, Al-Batran, Salah-Eddin, Schlemmer, Marcus, Bauer, Sebastian, Wardelmann, Eva, Sarlomo-Rikala, Maarit, Nilsson, Bengt, Sihto, Harri, Ballman, Karla V, Leinonen, Mika, DeMatteo, Ronald P, Reichardt, Peter
フォーマット: Artigo
言語:Inglês
出版事項: BlackWell Publishing Ltd 2014
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209960/
https://ncbi.nlm.nih.gov/pubmed/24737415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28669
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料